72
Participants
Start Date
September 1, 2025
Primary Completion Date
May 1, 2026
Study Completion Date
February 1, 2027
virtual reality hypnosis device
VRH group, in which patients will receive conventional sedation (remifentanil 0.1 mcg/kg/min and propofol 0.5 mg/kg if necessary) and a Virtual Reality headset with an environment chosen by the patient and hypnosis support with suggestions to reduce their anxiety.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER